Skip to main content
Caplight Logo









Replication Medical, Inc.

Replication Medical, Inc.

Private
Cranbury, New JerseyHealthcare & Life Scienceshttps://replicationmedical.com/

Last Round

Grant

Nov 11, 2010

Total Funding Raised

$15.24M

Company Overview

Replication Medical, Inc. is a medical device company that develops and manufactures implantable medical devices based on proprietary hydrogel technology for the treatment of spinal and musculoskeletal conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicehydrogel implantspinal surgeryminimally invasivebiomaterialspine implantmusculoskeletal therapybiomimetic implantepidural fibrosisspinal stenosisdegenerative disc diseasemedtechsurgical implantISO 13485FDA registered

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Replication Medical, Inc. Comparables

Compare Replication Medical, Inc. with similar companies based on industry and business-model similarity.

Replication Medical, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SpineOvations, Inc.
86%
FzioMed, Inc.
77%
Spine Wave
76%

Replication Medical, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 11, 2010
Series DSep 16, 2005
Series CMar 1, 2005

Replication Medical, Inc. Investors

Notable investors and investment history

Replication Medical, Inc. investors
InvestorRounds
Cardinal PartnersSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2010

    $244K grant received from the United States Federal Government.

Replication Medical, Inc. Filings

Explore SEC and related filing metadata, where available.

Replication Medical, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Replication Medical, Inc.'s valuation, stock price, and market status.

Is Replication Medical, Inc. a public or private company?

Replication Medical, Inc. is a private company.

What is the current stock price of Replication Medical, Inc.?

Replication Medical, Inc. is a private company, so its shares have no public market price. Caplight tracks Replication Medical, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Replication Medical, Inc. worth (valuation)?

Valuation information for Replication Medical, Inc. is not publicly available.

Can I buy Replication Medical, Inc. stock?

Replication Medical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Replication Medical, Inc.'s last funding round?

Replication Medical, Inc.'s most recent funding round was Grant on November 11, 2010.

Who are the main investors in Replication Medical, Inc.?

Key investors in Replication Medical, Inc. include Cardinal Partners.

Will Replication Medical, Inc. IPO soon?

No public IPO plans have been announced for Replication Medical, Inc..

How can I track Replication Medical, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Replication Medical, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersCranbury, New Jersey
Year Founded2001
Last FundingNov 11, 2010

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?